Literature DB >> 15942979

The host environment drives HIV-1 fitness.

Tim van Opijnen1, Ben Berkhout.   

Abstract

Viral fitness is defined by the ability of an individual genotype to produce infectious progeny in a specific environment. For HIV the environment is never constant but rather fluctuates in time and space. For instance, environmental factors that determine viral fitness during transmission from host to host are different to the pressures from either cytotoxic T-lymphocytes (CTLs) or antiviral drugs. Consequently, viral fitness is highly dependent on the environment and the accurate determination of this value therefore depends strongly on the chosen environmental setting. This review describes how the host environment imposes selective pressures on the virus that shape its genotype and fitness. The most important environments that the virus encounters throughout its life cycle and during natural infection are discussed. In order of appearance, CTLs are discussed, followed by neutralising antibodies and antiretroviral drug treatment. It then goes on to describe receptor molecules that mediate viral entry and intracellular restriction factors, which represent selective pressures that are present directly from the start of a natural infection. It concludes by discussing the complexity of viral fitness and how an accurate measure of viral fitness eventually may, for example, contribute to the improvement of antiretroviral therapy or help in the formulation of an optimal vaccination strategy. Copyright (c) 2005 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2005        PMID: 15942979     DOI: 10.1002/rmv.472

Source DB:  PubMed          Journal:  Rev Med Virol        ISSN: 1052-9276            Impact factor:   6.989


  12 in total

1.  Lack of association between HLA class II alleles and in vitro replication capacities of recombinant viruses encoding HIV-1 subtype C Gag-protease from chronically infected individuals.

Authors:  Jaclyn K Wright; Zabrina L Brumme; Boris Julg; Mary van der Stok; Zenele Mncube; Xiaojiang Gao; Jonathan M Carlson; Philip J R Goulder; Bruce D Walker; Mark A Brockman; Thumbi Ndung'u
Journal:  J Virol       Date:  2011-11-16       Impact factor: 5.103

Review 2.  Genomics meets HIV-1.

Authors:  Amalio Telenti; David B Goldstein
Journal:  Nat Rev Microbiol       Date:  2006-10-09       Impact factor: 60.633

3.  Analysis of infectious virus clones from two HIV-1 superinfection cases suggests that the primary strains have lower fitness.

Authors:  Antoinette C van der Kuyl; Karolina Kozaczynska; Kevin K Ariën; Youssef Gali; Victoria R Balázs; Stefan J Dekker; Fokla Zorgdrager; Guido Vanham; Ben Berkhout; Marion Cornelissen
Journal:  Retrovirology       Date:  2010-07-20       Impact factor: 4.602

4.  Increased sensitivity to broadly neutralizing antibodies of end-stage disease R5 HIV-1 correlates with evolution in Env glycosylation and charge.

Authors:  Marie Borggren; Johanna Repits; Jasminka Sterjovski; Hannes Uchtenhagen; Melissa J Churchill; Anders Karlsson; Jan Albert; Adnane Achour; Paul R Gorry; Eva Maria Fenyö; Marianne Jansson
Journal:  PLoS One       Date:  2011-06-16       Impact factor: 3.240

5.  Infectogenomics: insights from the host genome into infectious diseases.

Authors:  Paul Kellam; Robin A Weiss
Journal:  Cell       Date:  2006-02-24       Impact factor: 41.582

6.  Tracking the culprit: HIV-1 evolution and immune selection revealed by single-genome amplification.

Authors:  Zabrina L Brumme; Bruce D Walker
Journal:  J Exp Med       Date:  2009-06-01       Impact factor: 14.307

7.  LCMV glycosylation modulates viral fitness and cell tropism.

Authors:  Cyrille J Bonhomme; Kristeene A Knopp; Lydia H Bederka; Megan M Angelini; Michael J Buchmeier
Journal:  PLoS One       Date:  2013-01-07       Impact factor: 3.240

8.  Adaptation of HIV-1 depends on the host-cell environment.

Authors:  Tim van Opijnen; Anthony de Ronde; Maarten C Boerlijst; Ben Berkhout
Journal:  PLoS One       Date:  2007-03-07       Impact factor: 3.240

Review 9.  The population genetics of drug resistance evolution in natural populations of viral, bacterial and eukaryotic pathogens.

Authors:  Benjamin A Wilson; Nandita R Garud; Alison F Feder; Zoe J Assaf; Pleuni S Pennings
Journal:  Mol Ecol       Date:  2015-12-17       Impact factor: 6.185

10.  Characterization of two HIV-1 infectors during initial antiretroviral treatment, and the emergence of phenotypic resistance in reverse transcriptase-associated mutation patterns.

Authors:  Wei Guo; Jingwan Han; Daomin Zhuang; Siyang Liu; Yongjian Liu; Lin Li; Hanping Li; Zuoyi Bao; Fujiang Wang; Jingyun Li
Journal:  Virol J       Date:  2015-11-14       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.